PHS

PFM Health Sciences Portfolio holdings

AUM $988M
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+67.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$988M
AUM Growth
-$185M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1
+$20.8M
2
+$20.1M
3
+$19.3M
4
SYK icon
Stryker
SYK
+$18.5M
5
UNH icon
UnitedHealth
UNH
+$17.1M

Top Sells

1
+$150M
2
+$55.9M
3
+$38.9M
4
ISRG icon
Intuitive Surgical
ISRG
+$33M
5
COR icon
Cencora
COR
+$25.2M

Sector Composition

1 Healthcare 98.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMCI icon
76
Treace Medical Concepts
TMCI
$92.4M
$123K 0.01%
+50,000
AKRO
77
DELISTED
Akero Therapeutics
AKRO
– –
-248,079
ARQT icon
78
Arcutis Biotherapeutics
ARQT
$2.98B
– –
-360,460
AZN icon
79
AstraZeneca
AZN
$301B
– –
-61,795
BSX icon
80
Boston Scientific
BSX
$106B
– –
-28,648
COR icon
81
Cencora
COR
$69.7B
– –
-80,493
ELV icon
82
Elevance Health
ELV
$63.9B
– –
-60,776
ELVN icon
83
Enliven Therapeutics
ELVN
$1.75B
– –
-156,463
HIMS icon
84
Hims & Hers Health
HIMS
$3.59B
– –
-22,915
HOWL icon
85
Werewolf Therapeutics
HOWL
$30.7M
– –
-401,110
HUM icon
86
Humana
HUM
$21.6B
– –
-3,648
IRTC icon
87
iRhythm Holdings
IRTC
$3.99B
– –
-64,998
IWM icon
88
iShares Russell 2000 ETF
IWM
$71B
– –
0
LQDA icon
89
Liquidia Corp
LQDA
$3.13B
– –
0
MCK icon
90
McKesson
MCK
$113B
– –
-72,313
DFTX
91
Definium Therapeutics
DFTX
$1.74B
– –
-75,138
MRUS
92
DELISTED
Merus
MRUS
– –
-130,742
NTRA icon
93
Natera
NTRA
$28.1B
– –
-115,596
REGN icon
94
Regeneron Pharmaceuticals
REGN
$80.3B
– –
-19,890
SPY icon
95
State Street SPDR S&P 500 ETF Trust
SPY
$681B
– –
-21,210
TEVA icon
96
Teva Pharmaceuticals
TEVA
$36.2B
– –
-356,818
VRNA
97
DELISTED
Verona Pharma
VRNA
– –
-80,416
WST icon
98
West Pharmaceutical
WST
$17.7B
– –
-18,365
XBI icon
99
State Street SPDR S&P Biotech ETF
XBI
$8.12B
– –
0
1 2 3
4